| 0 |
Phenylalanine Metabolizing Enzyme [EPC] |
909 |
0.1861 |
| 1 |
Antirheumatic Agent [EPC] |
13751 |
0.1557 |
| 2 |
Interleukin-6 Receptor Antagonist [EPC] |
14341 |
0.1463 |
| 3 |
Selective T Cell Costimulation Modulator [EPC] |
14327 |
0.1324 |
| 4 |
Aminosalicylate [EPC] |
12180 |
0.1169 |
| 5 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
119 |
0.1102 |
| 6 |
Interleukin-17 Receptor A Antagonist [EPC] |
134 |
0.1100 |
| 7 |
Thymic Stromal Lymphopoietin Blocker [EPC] |
121 |
0.1066 |
| 8 |
Interferon alfa-2b [EPC] |
56 |
0.0993 |
| 9 |
Paramagnetic Contrast Agent [EPC] |
383 |
0.0899 |
| 10 |
Lead Chelator [EPC] |
6 |
0.0882 |
| 11 |
Folate Analog Metabolic Inhibitor [EPC] |
30532 |
0.0876 |
| 12 |
Cortisol Synthesis Inhibitor [EPC] |
8 |
0.0833 |
| 13 |
Interleukin-1 Receptor Antagonist [EPC] |
1027 |
0.0805 |
| 14 |
l-Triiodothyronine [EPC] |
4 |
0.0800 |
| 15 |
Parathyroid Hormone Analog [EPC] |
8385 |
0.0788 |
| 16 |
CD19-directed Cytolytic Antibody [EPC] |
11 |
0.0786 |
| 17 |
Selectin Blocker [EPC] |
89 |
0.0759 |
| 18 |
Interleukin-17A Antagonist [EPC] |
11160 |
0.0729 |
| 19 |
Type I Interferon Receptor Antagonist [EPC] |
30 |
0.0714 |
| 20 |
Prostacyclin Receptor Agonist [EPC] |
1373 |
0.0698 |
| 21 |
Vitamin D [EPC] |
17573 |
0.0692 |
| 22 |
Aromatase Inhibitor [EPC] |
6045 |
0.0688 |
| 23 |
Tumor Necrosis Factor Blocker [EPC] |
57478 |
0.0669 |
| 24 |
Vitamin B12 [EPC] |
17885 |
0.0659 |
| 25 |
Histamine-1 Receptor Antagonist [EPC] |
2408 |
0.0642 |
| 26 |
Calcitonin [EPC] |
182 |
0.0634 |
| 27 |
Partial Opioid Agonist/Antagonist [EPC] |
3 |
0.0625 |
| 28 |
Calcium [EPC] |
7717 |
0.0623 |
| 29 |
Vitamin C [EPC] |
20232 |
0.0623 |
| 30 |
Prostaglandin E1 Analog [EPC] |
904 |
0.0592 |
| 31 |
Purine Antimetabolite [EPC] |
4318 |
0.0582 |
| 32 |
Pyruvate Kinase Activator [EPC] |
12 |
0.0577 |
| 33 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
829 |
0.0574 |
| 34 |
Progestin Antagonist [EPC] |
201 |
0.0540 |
| 35 |
Human Immunoglobulin G [EPC] |
463 |
0.0530 |
| 36 |
Expectorant [EPC] |
8293 |
0.0529 |
| 37 |
Alkaloid [EPC] |
1144 |
0.0505 |
| 38 |
Anti-IgE [EPC] |
2752 |
0.0496 |
| 39 |
CD20-directed Cytolytic Antibody [EPC] |
10973 |
0.0494 |
| 40 |
Bile Acid Sequestrant [EPC] |
449 |
0.0490 |
| 41 |
Provitamin D2 Compound [EPC] |
14574 |
0.0488 |
| 42 |
Fluoroquinolone Antibacterial [EPC] |
4899 |
0.0475 |
| 43 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
924 |
0.0471 |
| 44 |
Non-Standardized Insect Allergenic Extract [EPC] |
189 |
0.0471 |
| 45 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
234 |
0.0469 |
| 46 |
Interleukin-12 Antagonist [EPC] |
3608 |
0.0464 |
| 47 |
Standardized Insect Venom Allergenic Extract [EPC] |
236 |
0.0454 |
| 48 |
RANK Ligand Inhibitor [EPC] |
7642 |
0.0441 |
| 49 |
Farnesoid X Receptor Agonist [EPC] |
256 |
0.0435 |
| 50 |
Vitamin B6 Analog [EPC] |
11 |
0.0426 |
| 51 |
Estrogen Receptor Antagonist [EPC] |
999 |
0.0418 |
| 52 |
Non-Standardized Fungal Allergenic Extract [EPC] |
136 |
0.0411 |
| 53 |
Lymphocyte Activation Gene-3 Blocker [EPC] |
4 |
0.0408 |
| 54 |
Blood Viscosity Reducer [EPC] |
134 |
0.0408 |
| 55 |
Interleukin-23 Antagonist [EPC] |
5155 |
0.0407 |
| 56 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
1176 |
0.0405 |
| 57 |
Reducing and Complexing Thiol [EPC] |
76 |
0.0404 |
| 58 |
Corticosteroid [EPC] |
39967 |
0.0400 |
| 59 |
Non-Standardized Plant Allergenic Extract [EPC] |
392 |
0.0399 |
| 60 |
Parenteral Iron Replacement [EPC] |
411 |
0.0395 |
| 61 |
Janus Kinase Inhibitor [EPC] |
3462 |
0.0391 |
| 62 |
Non-Standardized Food Allergenic Extract [EPC] |
540 |
0.0385 |
| 63 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
37679 |
0.0384 |
| 64 |
Autologous Cultured Cell [EPC] |
15 |
0.0384 |
| 65 |
Gonadotropin Releasing Hormone Receptor Antagonist [EPC] |
183 |
0.0383 |
| 66 |
Non-Standardized Animal Skin Allergenic Extract [EPC] |
2 |
0.0377 |
| 67 |
Endoglycosidase [EPC] |
100 |
0.0375 |
| 68 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
2544 |
0.0372 |
| 69 |
Nitrofuran Antibacterial [EPC] |
767 |
0.0369 |
| 70 |
Thiazide Diuretic [EPC] |
7011 |
0.0368 |
| 71 |
Potassium-sparing Diuretic [EPC] |
611 |
0.0367 |
| 72 |
Antiparasitic [EPC] |
171 |
0.0366 |
| 73 |
Non-Standardized House Dust Allergenic Extract [EPC] |
2 |
0.0364 |
| 74 |
Cannabinoid [EPC] |
287 |
0.0361 |
| 75 |
Contrast Agent for Ultrasound Imaging [EPC] |
178 |
0.0361 |
| 76 |
Pediculicide [EPC] |
172 |
0.0358 |
| 77 |
Vitamin A [EPC] |
1949 |
0.0355 |
| 78 |
5-Lipoxygenase Inhibitor [EPC] |
20 |
0.0355 |
| 79 |
Opioid Agonist [EPC] |
8644 |
0.0353 |
| 80 |
l-Thyroxine [EPC] |
5216 |
0.0353 |
| 81 |
Muscle Relaxant [EPC] |
1342 |
0.0352 |
| 82 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
574 |
0.0348 |
| 83 |
Nicotinic Acid [EPC] |
2109 |
0.0346 |
| 84 |
Folate Analog [EPC] |
23 |
0.0343 |
| 85 |
Progesterone [EPC] |
552 |
0.0342 |
| 86 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
5846 |
0.0338 |
| 87 |
Antimycobacterial [EPC] |
523 |
0.0335 |
| 88 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
306 |
0.0333 |
| 89 |
Aluminum Complex [EPC] |
644 |
0.0332 |
| 90 |
Barbiturate [EPC] |
343 |
0.0331 |
| 91 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
199 |
0.0329 |
| 92 |
Androgen Receptor Inhibitor [EPC] |
2090 |
0.0328 |
| 93 |
PCSK9 Inhibitor [EPC] |
4184 |
0.0326 |
| 94 |
alpha-Hydroxy Acid [EPC] |
45 |
0.0326 |
| 95 |
Methylxanthine [EPC] |
1371 |
0.0325 |
| 96 |
Antidiarrheal [EPC] |
9 |
0.0323 |
| 97 |
Classical Complement Pathway Inhibitor [EPC] |
2 |
0.0323 |
| 98 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
3950 |
0.0322 |
| 99 |
Small Interfering RNA [EPC] |
5 |
0.0321 |
| 100 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
2451 |
0.0320 |
| 101 |
Hedgehog Pathway Inhibitor [EPC] |
253 |
0.0318 |
| 102 |
Antidote [EPC] |
1878 |
0.0318 |
| 103 |
Sulfonamide Antibacterial [EPC] |
101 |
0.0316 |
| 104 |
Neonatal Fc Receptor Blocker [EPC] |
25 |
0.0315 |
| 105 |
HMG-CoA Reductase Inhibitor [EPC] |
11254 |
0.0313 |
| 106 |
Proton Pump Inhibitor [EPC] |
14881 |
0.0313 |
| 107 |
Phosphodiesterase 4 Inhibitor [EPC] |
4436 |
0.0311 |
| 108 |
Interleukin-13 Antagonist [EPC] |
29 |
0.0310 |
| 109 |
Thiazide-like Diuretic [EPC] |
1037 |
0.0307 |
| 110 |
Vitamin K [EPC] |
198 |
0.0304 |
| 111 |
Tetracycline-class Drug [EPC] |
1484 |
0.0300 |
| 112 |
Parathyroid Hormone [EPC] |
132 |
0.0300 |
| 113 |
Lincosamide Antibacterial [EPC] |
737 |
0.0293 |
| 114 |
Dihydropyridine Calcium Channel Blocker [EPC] |
7606 |
0.0292 |
| 115 |
Ergot Derivative [EPC] |
113 |
0.0292 |
| 116 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
1061 |
0.0284 |
| 117 |
Soluble Guanylate Cyclase Stimulator [EPC] |
704 |
0.0281 |
| 118 |
Leukotriene Receptor Antagonist [EPC] |
515 |
0.0280 |
| 119 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1901 |
0.0279 |
| 120 |
Non-Standardized Pollen Allergenic Extract [EPC] |
9 |
0.0279 |
| 121 |
Sucrose-specific Enzyme [EPC] |
2 |
0.0278 |
| 122 |
Serotonin Reuptake Inhibitor [EPC] |
1967 |
0.0277 |
| 123 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
256 |
0.0275 |
| 124 |
Isocitrate Dehydrogenase 1 Inhibitor [EPC] |
35 |
0.0272 |
| 125 |
Nitrate Vasodilator [EPC] |
2166 |
0.0271 |
| 126 |
Nitroimidazole Antimicrobial [EPC] |
1500 |
0.0271 |
| 127 |
Interferon alpha [EPC] |
1530 |
0.0269 |
| 128 |
beta-Adrenergic Blocker [EPC] |
7119 |
0.0267 |
| 129 |
beta Lactamase Inhibitor [EPC] |
103 |
0.0267 |
| 130 |
Erythroid Maturation Agent [EPC] |
26 |
0.0266 |
| 131 |
Cephalosporin Antibacterial [EPC] |
181 |
0.0266 |
| 132 |
Thyroid Stimulating Hormone [EPC] |
21 |
0.0266 |
| 133 |
Adrenocorticotropic Hormone [EPC] |
24 |
0.0265 |
| 134 |
Thrombopoietin Receptor Agonist [EPC] |
332 |
0.0263 |
| 135 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
168 |
0.0262 |
| 136 |
Bismuth [EPC] |
121 |
0.0259 |
| 137 |
Interleukin-5 Antagonist [EPC] |
758 |
0.0258 |
| 138 |
Estrogen [EPC] |
4169 |
0.0258 |
| 139 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1901 |
0.0254 |
| 140 |
Chloride Channel Activator [EPC] |
198 |
0.0249 |
| 141 |
Benzodiazepine [EPC] |
14865 |
0.0248 |
| 142 |
Platelet Aggregation Inhibitor [EPC] |
12591 |
0.0246 |
| 143 |
Quinolone Antimicrobial [EPC] |
192 |
0.0244 |
| 144 |
Amide Local Anesthetic [EPC] |
1553 |
0.0242 |
| 145 |
Recombinant Human Growth Hormone [EPC] |
331 |
0.0242 |
| 146 |
Xanthine Oxidase Inhibitor [EPC] |
3441 |
0.0241 |
| 147 |
CD52-directed Cytolytic Antibody [EPC] |
410 |
0.0239 |
| 148 |
Integrin Receptor Antagonist [EPC] |
5305 |
0.0239 |
| 149 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
370 |
0.0239 |
| 150 |
gamma-Aminobutyric Acid A Receptor Agonist [EPC] |
31 |
0.0237 |
| 151 |
Uric Acid-specific Enzyme [EPC] |
46 |
0.0236 |
| 152 |
Kinase Inhibitor [EPC] |
10291 |
0.0235 |
| 153 |
Angiotensin 2 Receptor Blocker [EPC] |
6646 |
0.0235 |
| 154 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
1054 |
0.0233 |
| 155 |
Antiarrhythmic [EPC] |
1760 |
0.0233 |
| 156 |
5-alpha Reductase Inhibitor [EPC] |
1406 |
0.0233 |
| 157 |
Phenothiazine [EPC] |
531 |
0.0231 |
| 158 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
2031 |
0.0230 |
| 159 |
alpha-Adrenergic Agonist [EPC] |
1154 |
0.0230 |
| 160 |
Aldosterone Antagonist [EPC] |
2604 |
0.0223 |
| 161 |
Vitamin D3 Analog [EPC] |
380 |
0.0222 |
| 162 |
Sympathomimetic-like Agent [EPC] |
630 |
0.0220 |
| 163 |
Melanin Synthesis Inhibitor [EPC] |
20 |
0.0218 |
| 164 |
Cardiac Glycoside [EPC] |
1402 |
0.0216 |
| 165 |
Aldehyde Dehydrogenase Inhibitor [EPC] |
18 |
0.0216 |
| 166 |
Macrolide Antimicrobial [EPC] |
907 |
0.0214 |
| 167 |
Sulfonylurea [EPC] |
2406 |
0.0214 |
| 168 |
Non-narcotic Antitussive [EPC] |
251 |
0.0213 |
| 169 |
Prostacycline Vasodilator [EPC] |
2208 |
0.0213 |
| 170 |
Phosphodiesterase 5 Inhibitor [EPC] |
2270 |
0.0213 |
| 171 |
Catecholamine Synthesis Inhibitor [EPC] |
1 |
0.0213 |
| 172 |
Loop Diuretic [EPC] |
7779 |
0.0212 |
| 173 |
alpha-Adrenergic Blocker [EPC] |
2500 |
0.0211 |
| 174 |
HER2/neu Receptor Antagonist [EPC] |
1180 |
0.0210 |
| 175 |
beta3-Adrenergic Agonist [EPC] |
615 |
0.0209 |
| 176 |
Gadolinium-based Contrast Agent [EPC] |
81 |
0.0208 |
| 177 |
Central Nervous System Stimulant [EPC] |
1378 |
0.0207 |
| 178 |
Central alpha-2 Adrenergic Agonist [EPC] |
988 |
0.0207 |
| 179 |
Catecholamine [EPC] |
1185 |
0.0206 |
| 180 |
Interferon gamma [EPC] |
26 |
0.0200 |
| 181 |
Nitrogen Binding Agent [EPC] |
2 |
0.0200 |
| 182 |
Bile Acid [EPC] |
300 |
0.0200 |
| 183 |
CD4-directed Blocking Antibody [EPC] |
7 |
0.0198 |
| 184 |
Complement Inhibitor [EPC] |
950 |
0.0196 |
| 185 |
Glucosylceramide Synthase Inhibitor [EPC] |
38 |
0.0196 |
| 186 |
Rifamycin Antimycobacterial [EPC] |
49 |
0.0194 |
| 187 |
Androgen [EPC] |
797 |
0.0193 |
| 188 |
Pyrimidine Synthesis Inhibitor [EPC] |
814 |
0.0192 |
| 189 |
Osmotic Laxative [EPC] |
3395 |
0.0190 |
| 190 |
Carbonic Anhydrase Inhibitor [EPC] |
308 |
0.0190 |
| 191 |
Plasma Volume Expander [EPC] |
44 |
0.0188 |
| 192 |
Polyene Antifungal [EPC] |
668 |
0.0187 |
| 193 |
Cholinergic Muscarinic Antagonist [EPC] |
596 |
0.0186 |
| 194 |
Somatostatin Analog [EPC] |
86 |
0.0183 |
| 195 |
Antifibrinolytic Agent [EPC] |
133 |
0.0181 |
| 196 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
915 |
0.0181 |
| 197 |
Nucleoside Analog Antiviral [EPC] |
1428 |
0.0180 |
| 198 |
Endothelin Receptor Antagonist [EPC] |
3001 |
0.0176 |
| 199 |
Serotonin-3 Receptor Antagonist [EPC] |
1615 |
0.0173 |
| 200 |
Nonergot Dopamine Agonist [EPC] |
394 |
0.0172 |
| 201 |
Interleukin-6 Antagonist [EPC] |
6 |
0.0171 |
| 202 |
P2Y12 Platelet Inhibitor [EPC] |
1616 |
0.0170 |
| 203 |
Stimulant Laxative [EPC] |
188 |
0.0169 |
| 204 |
Azole Antifungal [EPC] |
2008 |
0.0165 |
| 205 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1492 |
0.0165 |
| 206 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1449 |
0.0163 |
| 207 |
Sulfone [EPC] |
130 |
0.0161 |
| 208 |
Tricyclic Antidepressant [EPC] |
7 |
0.0161 |
| 209 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
2438 |
0.0161 |
| 210 |
Iron Chelator [EPC] |
424 |
0.0160 |
| 211 |
Histamine-2 Receptor Antagonist [EPC] |
4517 |
0.0159 |
| 212 |
Vitamin D Analog [EPC] |
260 |
0.0159 |
| 213 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
709 |
0.0156 |
| 214 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
216 |
0.0155 |
| 215 |
Estrogen Agonist/Antagonist [EPC] |
39 |
0.0153 |
| 216 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
630 |
0.0152 |
| 217 |
Interferon gamma Blocker [EPC] |
1 |
0.0152 |
| 218 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
228 |
0.0150 |
| 219 |
Factor Xa Inhibitor [EPC] |
5614 |
0.0148 |
| 220 |
Interferon beta [EPC] |
2867 |
0.0145 |
| 221 |
Complement 5a Receptor Antagonist [EPC] |
20 |
0.0144 |
| 222 |
Antimetabolite Immunosuppressant [EPC] |
165 |
0.0143 |
| 223 |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
104 |
0.0142 |
| 224 |
Influenza A M2 Protein Inhibitor [EPC] |
168 |
0.0141 |
| 225 |
Guanylate Cyclase-C Agonist [EPC] |
291 |
0.0141 |
| 226 |
CTLA-4-directed Blocking Antibody [EPC] |
475 |
0.0140 |
| 227 |
Antiseptic [EPC] |
47 |
0.0139 |
| 228 |
Leptin Analog [EPC] |
13 |
0.0139 |
| 229 |
Angiopoietin-like 3 Inhibitor [EPC] |
1 |
0.0139 |
| 230 |
Sclerosing Agent [EPC] |
5 |
0.0139 |
| 231 |
Insulin [EPC] |
657 |
0.0139 |
| 232 |
Anticholinergic [EPC] |
174 |
0.0138 |
| 233 |
Phosphodiesterase 3 Inhibitor [EPC] |
72 |
0.0138 |
| 234 |
Insulin Analog [EPC] |
5237 |
0.0136 |
| 235 |
Prostaglandin Analog [EPC] |
1074 |
0.0135 |
| 236 |
Cytochrome P450 3A Inhibitor [EPC] |
740 |
0.0132 |
| 237 |
Skin Test Antigen [EPC] |
29 |
0.0131 |
| 238 |
Tyrosine Kinase 2 Inhibitor [EPC] |
9 |
0.0131 |
| 239 |
Plasma Kallikrein Inhibitor [EPC] |
41 |
0.0130 |
| 240 |
Microtubule Inhibitor [EPC] |
1556 |
0.0130 |
| 241 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1498 |
0.0128 |
| 242 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
635 |
0.0128 |
| 243 |
Potassium Channel Blocker [EPC] |
869 |
0.0127 |
| 244 |
Anthelmintic [EPC] |
30 |
0.0127 |
| 245 |
Rifamycin Antibacterial [EPC] |
305 |
0.0127 |
| 246 |
Leukocyte Growth Factor [EPC] |
1437 |
0.0123 |
| 247 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
120 |
0.0122 |
| 248 |
Pyridone [EPC] |
436 |
0.0122 |
| 249 |
Glinide [EPC] |
84 |
0.0120 |
| 250 |
Protease Inhibitor [EPC] |
499 |
0.0120 |
| 251 |
Calcitonin Gene-related Peptide Antagonist [EPC] |
34 |
0.0120 |
| 252 |
Mood Stabilizer [EPC] |
2162 |
0.0119 |
| 253 |
Methylating Agent [EPC] |
10 |
0.0117 |
| 254 |
Erythropoiesis-stimulating Agent [EPC] |
768 |
0.0117 |
| 255 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
64 |
0.0116 |
| 256 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
550 |
0.0116 |
| 257 |
Pyrethroid [EPC] |
16 |
0.0114 |
| 258 |
Antileishmanial [EPC] |
3 |
0.0114 |
| 259 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
8 |
0.0113 |
| 260 |
Anti-anginal [EPC] |
195 |
0.0113 |
| 261 |
Lipoglycopeptide Antibacterial [EPC] |
9 |
0.0112 |
| 262 |
Monobactam Antibacterial [EPC] |
24 |
0.0111 |
| 263 |
Antiprotozoal [EPC] |
101 |
0.0111 |
| 264 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
504 |
0.0110 |
| 265 |
CCR5 Co-receptor Antagonist [EPC] |
23 |
0.0110 |
| 266 |
Anti-epileptic Agent [EPC] |
2117 |
0.0109 |
| 267 |
GLP-2 Analog [EPC] |
104 |
0.0109 |
| 268 |
Non-Standardized Chemical Allergen [EPC] |
243 |
0.0108 |
| 269 |
Aromatic Amino Acid [EPC] |
556 |
0.0108 |
| 270 |
Antimalarial [EPC] |
77 |
0.0108 |
| 271 |
Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC] |
7 |
0.0102 |
| 272 |
Retinoid [EPC] |
2316 |
0.0102 |
| 273 |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] |
15 |
0.0101 |
| 274 |
Vitamin D2 Analog [EPC] |
152 |
0.0100 |
| 275 |
Opioid Antagonist [EPC] |
7 |
0.0099 |
| 276 |
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
22 |
0.0099 |
| 277 |
Programmed Death Ligand-1 Blocker [EPC] |
107 |
0.0098 |
| 278 |
Prostacycline [EPC] |
95 |
0.0097 |
| 279 |
Antihypoglycemic Agent [EPC] |
29 |
0.0097 |
| 280 |
Aminoglycoside Antibacterial [EPC] |
328 |
0.0096 |
| 281 |
Photoenhancer [EPC] |
14 |
0.0096 |
| 282 |
Chemokine Receptor Type 4 Interaction [EPC] |
9 |
0.0096 |
| 283 |
BCL-2 Inhibitor [EPC] |
372 |
0.0096 |
| 284 |
Glycopeptide Antibacterial [EPC] |
472 |
0.0095 |
| 285 |
Adenosine Receptor Agonist [EPC] |
58 |
0.0094 |
| 286 |
GLP-1 Receptor Agonist [EPC] |
1992 |
0.0093 |
| 287 |
mu-Opioid Receptor Agonist [EPC] |
24 |
0.0092 |
| 288 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1336 |
0.0092 |
| 289 |
Hemoglobin S Polymerization Inhibitor [EPC] |
179 |
0.0091 |
| 290 |
Amyloid Beta-directed Antibody [EPC] |
4 |
0.0090 |
| 291 |
Nuclear Export Inhibitor [EPC] |
48 |
0.0090 |
| 292 |
Oxytocic [EPC] |
21 |
0.0089 |
| 293 |
alpha-Glucosidase Inhibitor [EPC] |
34 |
0.0088 |
| 294 |
Lymphocyte Growth Factor [EPC] |
8 |
0.0087 |
| 295 |
Oxazolidinone Antibacterial [EPC] |
187 |
0.0087 |
| 296 |
Lipopeptide Antibacterial [EPC] |
101 |
0.0086 |
| 297 |
Thalidomide Analog [EPC] |
3423 |
0.0083 |
| 298 |
Monoamine Oxidase Inhibitor [EPC] |
22 |
0.0083 |
| 299 |
Tubulin Inhibiting Agent [EPC] |
2 |
0.0082 |
| 300 |
Copper-containing Intrauterine Device [EPC] |
292 |
0.0081 |
| 301 |
Potassium Binder [EPC] |
112 |
0.0080 |
| 302 |
Carnitine Analog [EPC] |
19 |
0.0078 |
| 303 |
Atypical Antipsychotic [EPC] |
3385 |
0.0078 |
| 304 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
90 |
0.0077 |
| 305 |
Progestin [EPC] |
1944 |
0.0077 |
| 306 |
Hematopoietic Stem Cell Mobilizer [EPC] |
9 |
0.0077 |
| 307 |
CD30-directed Immunoconjugate [EPC] |
51 |
0.0077 |
| 308 |
Sigma-1 Agonist [EPC] |
50 |
0.0076 |
| 309 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
34 |
0.0076 |
| 310 |
Alkylating Drug [EPC] |
1416 |
0.0074 |
| 311 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
16 |
0.0073 |
| 312 |
Proteasome Inhibitor [EPC] |
664 |
0.0073 |
| 313 |
CD38-directed Cytolytic Antibody [EPC] |
208 |
0.0072 |
| 314 |
Osmotic Diuretic [EPC] |
29 |
0.0070 |
| 315 |
Nucleoside Metabolic Inhibitor [EPC] |
1651 |
0.0070 |
| 316 |
Acetylcholine Release Inhibitor [EPC] |
517 |
0.0070 |
| 317 |
Cholinesterase Inhibitor [EPC] |
105 |
0.0070 |
| 318 |
Anti-coagulant [EPC] |
39 |
0.0067 |
| 319 |
Oxaborole Antifungal [EPC] |
5 |
0.0066 |
| 320 |
Platinum-based Drug [EPC] |
1287 |
0.0066 |
| 321 |
Medium-chain Triglyceride [EPC] |
2 |
0.0066 |
| 322 |
Radiographic Contrast Agent [EPC] |
118 |
0.0065 |
| 323 |
Intestinal Lipase Inhibitor [EPC] |
161 |
0.0065 |
| 324 |
Melatonin Receptor Agonist [EPC] |
72 |
0.0065 |
| 325 |
Antisense Oligonucleotide [EPC] |
48 |
0.0064 |
| 326 |
Cholinergic Nicotinic Agonist [EPC] |
341 |
0.0062 |
| 327 |
Vasopressin V2 Receptor Antagonist [EPC] |
56 |
0.0062 |
| 328 |
Orexin Receptor Antagonist [EPC] |
84 |
0.0061 |
| 329 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
103 |
0.0061 |
| 330 |
Partial Opioid Agonist [EPC] |
478 |
0.0060 |
| 331 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
6 |
0.0057 |
| 332 |
Pleuromutilin Antibacterial [EPC] |
4 |
0.0056 |
| 333 |
Nucleoside Analog Antifungal [EPC] |
5 |
0.0056 |
| 334 |
Radioactive Diagnostic Agent [EPC] |
8 |
0.0054 |
| 335 |
Aryl Hydrocarbon Receptor Agonist [EPC] |
3 |
0.0053 |
| 336 |
Typical Antipsychotic [EPC] |
106 |
0.0053 |
| 337 |
Topoisomerase Inhibitor [EPC] |
293 |
0.0052 |
| 338 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
36 |
0.0052 |
| 339 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
3 |
0.0051 |
| 340 |
Penem Antibacterial [EPC] |
7 |
0.0049 |
| 341 |
Vasoconstrictor [EPC] |
1 |
0.0049 |
| 342 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
4 |
0.0048 |
| 343 |
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
60 |
0.0047 |
| 344 |
Benzothiazole [EPC] |
9 |
0.0045 |
| 345 |
Asparagine-specific Enzyme [EPC] |
47 |
0.0045 |
| 346 |
Dopamine-2 Receptor Antagonist [EPC] |
25 |
0.0045 |
| 347 |
Ester Local Anesthetic [EPC] |
2 |
0.0044 |
| 348 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
68 |
0.0044 |
| 349 |
Tetracycline-class Antibacterial [EPC] |
22 |
0.0044 |
| 350 |
CD19-directed Chimeric Antigen Receptor [EPC] |
35 |
0.0043 |
| 351 |
Neuraminidase Inhibitor [EPC] |
11 |
0.0042 |
| 352 |
Gonadotropin [EPC] |
6 |
0.0042 |
| 353 |
Phosphate Binder [EPC] |
10 |
0.0041 |
| 354 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
20 |
0.0040 |
| 355 |
CD22-directed Immunoconjugate [EPC] |
8 |
0.0039 |
| 356 |
Cytomegalovirus pUL97 Kinase Inhibitor [EPC] |
3 |
0.0039 |
| 357 |
Hypoxia-inducible Factor Inhibitor [EPC] |
2 |
0.0038 |
| 358 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
6 |
0.0038 |
| 359 |
Human Platelet-derived Growth Factor [EPC] |
8 |
0.0038 |
| 360 |
CD33-directed Immunoconjugate [EPC] |
12 |
0.0038 |
| 361 |
Echinocandin Antifungal [EPC] |
21 |
0.0037 |
| 362 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
49 |
0.0034 |
| 363 |
Interleukin-2 Receptor Blocking Antibody [EPC] |
30 |
0.0034 |
| 364 |
Lipid-based Polyene Antifungal [EPC] |
47 |
0.0034 |
| 365 |
Macrolide Antibacterial [EPC] |
6 |
0.0034 |
| 366 |
Photoactivated Radical Generator [EPC] |
2 |
0.0033 |
| 367 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
16 |
0.0033 |
| 368 |
CD123 Interaction [EPC] |
1 |
0.0032 |
| 369 |
Benzodiazepine Antagonist [EPC] |
2 |
0.0031 |
| 370 |
Arteriolar Vasodilator [EPC] |
107 |
0.0031 |
| 371 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
120 |
0.0031 |
| 372 |
Selective T Cell Costimulation Blocker [EPC] |
10 |
0.0030 |
| 373 |
General Anesthetic [EPC] |
94 |
0.0028 |
| 374 |
Mucocutaneous Epithelial Cell Growth Factor [EPC] |
1 |
0.0027 |
| 375 |
Lipid Emulsion [EPC] |
5 |
0.0026 |
| 376 |
Histone Deacetylase Inhibitor [EPC] |
7 |
0.0025 |
| 377 |
Actinomycin [EPC] |
5 |
0.0021 |
| 378 |
Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC] |
1 |
0.0020 |
| 379 |
Carbamoyl Phosphate Synthetase 1 Activator [EPC] |
1 |
0.0019 |
| 380 |
Radioligand Therapeutic Agent [EPC] |
3 |
0.0015 |
| 381 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
16 |
0.0015 |
| 382 |
Cytolytic Agent [EPC] |
2 |
0.0009 |
| 383 |
Humanized Monoclonal Antibody Fragment [EPC] |
1 |
0.0008 |
| 384 |
Recombinant Human Nerve Growth Factor [EPC] |
3 |
0.0007 |
| 385 |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
2 |
0.0001 |